A clinical drug–drug interaction (DDI) study was designed to evaluate the effect of single and multiple oral doses of encorafenib on the single oral dose pharmacokinetics (PK) of the cytochrome P450 (CYP) enzyme probe substrates, losartan (CYP2C9), midazolam (CYP3A4), caffeine (CYP1A2), omeprazole (CYP2C19), and dextromethorphan (CYP2D6) administered ...
Joseph Piscitelli +6 more
wiley +1 more source
Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and CREB3L2::PPARγ Fusion. [PDF]
Dennis CJ, Argyris PP, Cipriani NA.
europepmc +1 more source
Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP). [PDF]
Jang E, Kim K, Jung CK, Bae JS, Kim JS.
europepmc +1 more source
Expression of claudin 1, 4 and 7 in thyroid neoplasms
Dinç Süren +9 more
openalex +2 more sources
Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm? [PDF]
Renata M. Hirosawa +9 more
openalex +1 more source
ABSTRACT Background The third edition of the Bethesda system for reporting thyroid cytopathology recommends a simplified two‐tiered subclassification of atypia of undetermined significance (AUS), dividing cases into AUS with nuclear atypia (AUS‐Nuclear) and other atypia (AUS‐Other).
Pocholo D. Santos +2 more
wiley +1 more source
Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features Arising in the Thyroglossal Duct: A Case Report and Literature Review. [PDF]
Momii M, Umemoto S, Tei T, Hirano T.
europepmc +1 more source
Non-invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Lowers the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories. [PDF]
Al-Maghrabi H +7 more
europepmc +1 more source
Pitfalls in the Diagnosis of Thyroid Neoplasms
J, Rosai, M L, Carcangiu
openaire +2 more sources

